<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen Y</submitter><funding>the Natural Science Foundation of Fujian Province</funding><funding>National Natural Science Foundation of China</funding><pagination>13022</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9656704</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(21)</volume><pubmed_abstract>Heterozygous variants in the hepatocyte nuclear factor 1a (HNF1a) cause MODY3 (maturity-onset diabetes of the young, type 3). In this study, we found a case of novel HNF1a p.Gln125* (HNF1a-Q125ter) variant clinically. However, the molecular mechanism linking the new HNF1a variant to impaired islet β-cell function remains unclear. Firstly, a similar HNF1a-Q125ter variant in zebrafish (&lt;i>hnf1a&lt;sup>+/-&lt;/sup>&lt;/i>) was generated by CRISPR/Cas9. We further crossed &lt;i>hnf1a&lt;sup>+/-&lt;/sup>&lt;/i> with several zebrafish reporter lines to investigate pancreatic β-cell function. Next, we introduced HNF1a-Q125ter and HNF1a shRNA plasmids into the Ins-1 cell line and elucidated the molecular mechanism. &lt;i>hnf1a&lt;sup>+/-&lt;/sup>&lt;/i> zebrafish significantly decreased the β-cell number, insulin expression, and secretion. Moreover, β cells in &lt;i>hnf1a&lt;sup>+/-&lt;/sup>&lt;/i> dilated ER lumen and increased the levels of ER stress markers. Similar ER-stress phenomena were observed in an HNF1a-Q125ter-transfected Ins-1 cell. Follow-up investigations demonstrated that HNF1a-Q125ter induced ER stress through activating the PERK/eIF2a/ATF4 signaling pathway. Our study found a novel loss-of-function HNF1a-Q125ter variant which induced β-cell dysfunction by activating ER stress via the PERK/eIF2a/ATF4 signaling pathway.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Novel Loss-of-Function Variant in HNF1a Induces β-Cell Dysfunction through Endoplasmic Reticulum Stress.</pubmed_title><pmcid>PMC9656704</pmcid><funding_grant_id>8207033519</funding_grant_id><funding_grant_id>2021J011363</funding_grant_id><pubmed_authors>Tian J</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Huang C</pubmed_authors><pubmed_authors>Zhao Q</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Huang B</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Jia J</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel Loss-of-Function Variant in HNF1a Induces β-Cell Dysfunction through Endoplasmic Reticulum Stress.</name><description>Heterozygous variants in the hepatocyte nuclear factor 1a (HNF1a) cause MODY3 (maturity-onset diabetes of the young, type 3). In this study, we found a case of novel HNF1a p.Gln125* (HNF1a-Q125ter) variant clinically. However, the molecular mechanism linking the new HNF1a variant to impaired islet β-cell function remains unclear. Firstly, a similar HNF1a-Q125ter variant in zebrafish (&lt;i>hnf1a&lt;sup>+/-&lt;/sup>&lt;/i>) was generated by CRISPR/Cas9. We further crossed &lt;i>hnf1a&lt;sup>+/-&lt;/sup>&lt;/i> with several zebrafish reporter lines to investigate pancreatic β-cell function. Next, we introduced HNF1a-Q125ter and HNF1a shRNA plasmids into the Ins-1 cell line and elucidated the molecular mechanism. &lt;i>hnf1a&lt;sup>+/-&lt;/sup>&lt;/i> zebrafish significantly decreased the β-cell number, insulin expression, and secretion. Moreover, β cells in &lt;i>hnf1a&lt;sup>+/-&lt;/sup>&lt;/i> dilated ER lumen and increased the levels of ER stress markers. Similar ER-stress phenomena were observed in an HNF1a-Q125ter-transfected Ins-1 cell. Follow-up investigations demonstrated that HNF1a-Q125ter induced ER stress through activating the PERK/eIF2a/ATF4 signaling pathway. Our study found a novel loss-of-function HNF1a-Q125ter variant which induced β-cell dysfunction by activating ER stress via the PERK/eIF2a/ATF4 signaling pathway.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-25T23:35:23.022Z</modification><creation>2025-04-06T09:23:29.497Z</creation></dates><accession>S-EPMC9656704</accession><cross_references><pubmed>36361808</pubmed><doi>10.3390/ijms232113022</doi></cross_references></HashMap>